Jamie Taylor, OD
Optometrist · Ponte Vedra Beach, FLNPI 1922191808
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 68.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,569 and has fallen 96.6% since, to $86 in 2025.
Across 49 payments — averaging $67.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Alcon$361
- Bausch & Lomb, A Division Of Bausch Health US, LLC$342
- Coopervision Inc.$157
- Shire North American Group Inc$93
- Teva Pharmaceuticals USA, Inc.$55
- plus $23 from 1 others
What the payments were for
- Consulting fees$201%
- Speaking & faculty fees$1,80055%
- Travel & lodging$221%
- Food & beverage$1,45144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 22 | $2,262 |
| Alcon | 9 | $361 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $342 |
| Coopervision Inc. | 4 | $157 |
| Shire North American Group Inc | 1 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Aerie Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,909
- BTOD$112
- BIOTRUE ONE DAY$109
- Clariti Contact Lens$106
- DAILIES$101
How this compares
$3,293 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $5,569 |
| Azelastine Hcl | 25 | $475 |
| Latanoprost | 16 | $148 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Ponte Vedra Beach
- William SmithPonte Vedra Beach$41K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.